Home
Seagen

Seagen Market Share Analysis for July 2026

discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.

Health > Biotechnology and Pharmaceuticals

Domainseagen.com

Year Founded1998

Employees1001 - 5000

Annual Revenue> $1B

Seagen

Seagen (including company regionals)

seagen.com

See more website traffic and engagement information

Seagen Revenue up to July 2026 is > 1B

revenue generated by Seagen top domains

Seagen top domains revenue over 3 years

Revenue for Seagen top domains

seagen.com> 1B

See more with Sales Intelligence

Total visits to Seagen's top domains

Understand Seagen market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Seagen's top domains

Analyze Seagen engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Seagen's top domains

See how Seagen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Seagen top competitors by domain

Top similar sites in July 2026, ranked by their affinity

seattlegenetics.comCompany NameSeattle GeneticsEmployees1001 - 5000HQUnited StatesAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Seagen

These are the website technologies, by industry, used by Seagen top domains

Content Management System (3)

Web Dot Com

Advertising (2)

PubMatic

Audio Video Media (2)

Vimeo

Marketing (2)

Google Marketing Platform

More Technologies

7

See all

News & Signals from Seagen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSeagen Inc. invests into assets: facility in the amount of $350M in Everett, Washington, United States, Northern America, Americas.Seagen invested approximately $350 million to build out the facility, which was designed for drug manufacturing, quality-control labs, warehousing and distribution.

NewsSeagen Inc. invests into assets: biomanufacturing facility in the amount of $350M in Everett, Washington, United States, Northern America, Americas.The site was originally leased to Seagen that had invested approximately $350 million to build out a biomanufacturing facility but never moved in after being acquired in 2023 by Pfizer.

NewsNicacio leaves Seagen Inc..Nicacio comes from the antibody-drug-conjugate world: most recently CMO at Protara Therapeutics, and before that a series of roles at Seagen from 2017 to 2023, the ADC pioneer Pfizer acquired at the end of 2023.